IRMD IRadimed Corporation
HealthcareAs of 2026-05-26
Valuation
View DetailsP/E (TTM)
53.11
PEG
3.15
P/B
11.95
P/S
13.64
EV/EBITDA
36.70
DCF Value
$43.35
FCF Yield
2.0%
Div Yield
1.3%
Margins & Returns
Gross Margin
76.8%
Operating Margin
32.4%
Net Margin
27.4%
ROE
24.5%
ROA
20.6%
ROIC
21.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $22.0M | $5.8M | $— |
| Q4 null | $22.7M | $6.4M | $— |
| FY null | $83.8M | $22.5M | $— |
| Q3 null | $21.2M | $5.6M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$120.00
Target (Median)
$120.00
Target Range
$120.00 - $120.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.91
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.